ctrl K

Price Alert

InMed Pharmaceuticals Inc... (INM)

NASDAQ: INM · Real-Time Price · USD

2.33

-0.01 (-0.43%)

At close: Aug 15, 2025, 1:09 PM

InMed Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	6.57M	8.91M	6.18M	7.36M
Short-Term Investments	43.06M	44.42M	44.8K	46.46K
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	100K	104.91K	176.64K	14.65K
Receivables	352.84K	260.4K	88.03K	11.92K
Inventory	1.24M	1.62M	2.49M	-955.81M
Other Current Assets	477.75K	542.46K	44.8K	n/a
Total Current Assets	8.69M	11.33M	9.6M	8.38M
Property-Plant & Equipment	1.25M	723.43K	904.25K	326.6K
Goodwill & Intangibles	1.78M	1.95M	2.11M	1.06M
Total Long-Term Assets	3.13M	2.77M	3.19M	1.4M
Total Assets	11.82M	14.11M	12.79M	9.78M
Account Payables	626.19K	544.18K	1.17M	775.13K
Deferred Revenue	n/a	-2B	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	539.54K	558.48K	139.12K	880.21K
Total Current Liabilities	1.97M	2M	3.32M	2.22M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	644.87K	15.99K	389.5K	189.29K
Total Liabilities	2.62M	2.02M	3.71M	2.4M
Total Debt	962.66K	391.71K	793.77K	269.77K
Common Stock	82.78M	77.62M	70.72M	60.59M
Retained Earnings	-109.08M	-101.4M	-93.45M	-74.85M
Comprehensive Income	128.57K	128.57K	128.57K	128.57K
Shareholders Equity	9.21M	12.09M	9.08M	7.38M
Total Investments	43.06M	44.42M	44.8K	46.46K